What this study is
The PREDICT 3 study will build on previous research in over 2,000 individuals to further refine machine learning models that predict individual responses to foods, with the aim of advancing precision nutrition science and individualized dietary advice. The study incorporates both standardized and controlled dietary intervention, for the purpose of testing postprandial responses to specific mixed meals, in addition to a free-living period with a dietary record for measuring responses to a large variety of meals consumed in a realistic context, where the role of external factors (e.g. exercise, sleep, time of day) on postprandial responses may be determined. For the first time this PREDICT study is built on top of a commercial product which will allow access to a much larger group of participants who are already collecting large amounts of data through digital and biochemical devices that can contribute to science.
What's being tested
- Dietary Intervention
Intervention · OTHER
To carry out a dietary intervention using standardized test meals, where the participant's postprandial response to the meal is measured and is used to predict their postprandial responses to other foods, along with input variables including metabolic profile, anthropometry, sleep and exercise.
Study details
- Sponsor
- Zoe Global Limited
- Conditions
- Diabetes · Heart Diseases · Diet Habit · Diet Modification · Healthy · Obesity · Metabolism · Microbial Colonization
- Enrolling
- 250,000 people
- Starts
- 2020-07-20
- Est. completion
- 2030-01-01
- Design
- Open-label, single group
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years and overSex ALLHealthy volunteers AcceptedYou may qualify if
- Enrolled in the commercial ZOE testing program
- Any sex
- Minimum 18 years of age (minimum 19 years of age in Alabama and Nebraska due to state laws)
- Body mass index (BMI) of greater than or equal to 16.5 kg/m2.
- Living in the continental US states, other than in New York (excluded from the ZOE testing product also as they are unable to access the dried blood spot service provided by Quest), or living in the UK
- Able and willing to comply with the study protocol and provide informed consent.
- Under care for chronic medical conditions (including eating disorders, type 1 diabetes, type 2 diabetes), and confirm they have checked with their primary care physician that this study is safe for them (US cohort only)
You can't join if
- Cannot safely eat the pre-made test meals which contain standard US ingredients, e.g. due to allergy or recent gastrointestinal surgery, or are unwilling to consume these foods.
- Are pregnant.
- Have had a heart attack (myocardial infarction), stroke/transient ischemic attack (TIA), or major surgery in the last two months.
- Are unable to read and write in English, as the ZOE app is only available in English.
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (2)
2 openZoe US Inc.
Needham, Massachusetts, United States
- Brad Reardon · Contact+1866-771-7478hello@joinzoe.com
Recruiting
1 site outside the US
King's College London
London, United Kingdom
- Inbar Linenberg · Contactinbar@joinzoe.com
- Sarah Berry · Contactsarah.e.berry@kcl.ac.uk
- Sarah E Berry, PhD · Principal investigator
Recruiting
Study team
Sponsor
Zoe Global Limited
Study ID PREDICT 3
Principal investigator
Tim Spector, PhD
Zoe Global Limited
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.